Literature DB >> 29032451

Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

Yohann Dabi1, Mohammed El Mrini1, Igor Duquesnes1, Nicolas Barry Delongchamps1, Mathilde Sibony2, Marc Zerbib1, Evanguelos Xylinas3.   

Abstract

PURPOSE: To evaluate the association between body mass index (BMI) and oncological outcomes in patients treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).
METHODS: We retrospectively reviewed 237 consecutive patients treated with RNU for UTUC at our institution between 1990 and 2012. Univariable and multivariable cox regression models investigated the association of BMI with disease recurrence, cancer-specific mortality, and overall mortality.
RESULTS: From the 237 patients, 104 (44%) had a BMI < 25 kg/m2, 88 (37%) had a BMI between 25 and 29.9 kg/m2, and 45 (19%) had a BMI ≥ 30 kg/m2 at the time of surgery. Within a median follow-up of 44 months (IQR: 24-79), 53 patients (22.4%) experienced a disease recurrence, 85 patients (35.9%) had bladder recurrence, and 44 patients (18.6%) died from the disease. The 5 year recurrence-free and cancer-specific survival rates were, respectively, 32 and 56% for BMI ≥ 30 kg/m2, 45 and 74% for patients with BMI 25-29.9 kg/m2, and 69 and 81% for patients with BMI < 25 kg/m2. In multivariable analyses that adjusted for the effects of the standard clinico-pathological features, BMI ≥ 30 kg/m2 was associated with a higher risk of disease recurrence (HR 3.23; 95% CI 2.3-6.6, p < 0.001) and cancer-specific mortality (HR 3.84; 95% CI 2.8-6.5; p < 0.001).
CONCLUSIONS: Obesity was independently associated with higher risks of disease recurrence and cancer-specific mortality in patients treated with RNU for UTUC.

Entities:  

Keywords:  Cancer-specific mortality; Disease recurrence; Obesity; Prognostic factors; Radical nephroureterectomy; Upper tract urothelial carcinoma

Mesh:

Year:  2017        PMID: 29032451     DOI: 10.1007/s00345-017-2095-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  17 in total

1.  A prospective study of obesity and cancer risk (Sweden).

Authors:  A Wolk; G Gridley; M Svensson; O Nyrén; J K McLaughlin; J F Fraumeni; H O Adam
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

2.  Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.

Authors:  Behfar Ehdaie; Thomas F Chromecki; Richard K Lee; Yair Lotan; Vitaly Margulis; Pierre I Karakiewicz; Giacomo Novara; Jay D Raman; Casey Ng; William T Lowrance; Douglas S Scherr; Shahrokh F Shariat
Journal:  J Urol       Date:  2011-05-14       Impact factor: 7.450

3.  Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Evanguelos Xylinas; Luis A Kluth; Malte Rieken; Richard K Lee; Maya Elghouayel; Vicenzo Ficarra; Vitaly Margulis; Yair Lotan; Morgan Rouprêt; Juan I Martinez-Salamanca; Kazumasa Matsumoto; Christian Seitz; Pierre I Karakiewicz; Marc Zerbib; Douglas S Scherr; Shahrokh F Shariat
Journal:  BJU Int       Date:  2014-07       Impact factor: 5.588

Review 4.  High Neutrophil-to-lymphocyte Ratio as Prognostic Factor in Patients Affected by Upper Tract Urothelial Cancer: A Systematic Review and Meta-analysis.

Authors:  Michele Marchioni; Luca Cindolo; Riccardo Autorino; Giulia Primiceri; Davide Arcaniolo; Marco De Sio; Luigi Schips
Journal:  Clin Genitourin Cancer       Date:  2016-12-29       Impact factor: 2.872

5.  Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women.

Authors:  Crystal N Holick; Edward L Giovannucci; Meir J Stampfer; Dominique S Michaud
Journal:  Int J Cancer       Date:  2007-01-01       Impact factor: 7.396

6.  Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Masayuki Hagiwara; Eiji Kikuchi; Nobuyuki Tanaka; Kazuhiro Matsumoto; Hiroki Ide; Akira Miyajima; Takeshi Masuda; So Nakamura; Mototsugu Oya
Journal:  J Urol       Date:  2013-01-14       Impact factor: 7.450

7.  Increased body mass index predicts increased blood loss during radical cystectomy.

Authors:  Sam S Chang; Bruce Jacobs; Nancy Wells; Joseph A Smith; Michael S Cookson
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Impact of body mass index on radical cystectomy.

Authors:  Cheryl T Lee; Rodney L Dunn; Bert T Chen; Daya P Joshi; Jaqueline Sheffield; James E Montie
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

Review 9.  Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature.

Authors:  Joseph J Crivelli; Evanguelos Xylinas; Luis A Kluth; Malte Rieken; Michael Rink; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-06-19       Impact factor: 20.096

10.  Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy.

Authors:  Tobias Maurer; Jean Maurer; Margitta Retz; Roger Paul; Niko Zantl; Jurgen E Gschwend; Uwe Treiber
Journal:  Urol Int       Date:  2009-06-08       Impact factor: 2.089

View more
  6 in total

1.  Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center.

Authors:  Xiang Dai; Fei Wang; Yiqing Du; Caipeng Qin; Shicong Lai; Yuxuan Song; Zixiong Huang; Songchen Han; Xiaopeng Zhang; Tao Xu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

2.  The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects.

Authors:  Xiao-Fan Peng; Xiang-Yu Meng; Cheng Wei; Zhen-Hua Xing; Jia-Bin Huang; Zhen-Fei Fang; Xin-Qun Hu; Qi-Ming Liu; Zhao-Wei Zhu; Sheng-Hua Zhou
Journal:  Cancer Manag Res       Date:  2018-11-26       Impact factor: 3.989

Review 3.  Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.

Authors:  Matteo Santoni; Alessia Cimadamore; Francesco Massari; Francesco Piva; Gaetano Aurilio; Angelo Martignetti; Marina Scarpelli; Vincenzo Di Nunno; Lidia Gatto; Nicola Battelli; Liang Cheng; Antonio Lopez-Beltran; Rodolfo Montironi
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

4.  The Prognostic Value of Body Mass Index in Patients With Urothelial Carcinoma After Surgery: A Systematic Review and Meta-Analysis.

Authors:  Zhiqiang Yang; Yunjin Bai; Xu Hu; Xiaoming Wang; Ping Han
Journal:  Dose Response       Date:  2020-12-15       Impact factor: 2.658

5.  Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma.

Authors:  Shota Omura; Satoru Taguchi; Shogo Miyagawa; Ryuki Matsumoto; Mio Samejima; Naoki Ninomiya; Kazuki Masuda; Yu Nakamura; Tsuyoshi Yamaguchi; Manami Kinjo; Mitsuhiro Tambo; Takatsugu Okegawa; Eiji Higashihara; Hiroshi Fukuhara
Journal:  BMC Urol       Date:  2020-08-28       Impact factor: 2.264

Review 6.  Oncologic outcomes of radical nephroureterectomy (RNU).

Authors:  Alexander P Kenigsberg; Xiaosong Meng; Rashed Ghandour; Vitaly Margulis
Journal:  Transl Androl Urol       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.